Early into COVID, human challenge trials were considered, but usually as alternatives to conventional randomized controlled trials. Instead, assessment of authorized COVID vaccines, of further COVID vaccines, and of vaccines against future pandemics should combine both designs, in five different ways, including a wholly novel one that we elaborate, Viz., combining data from both designs to answer a single question.
All Keywords
【저자키워드】 coronavirus, Vaccines, Ethics, randomized controlled trials as topic, adaptive clinical trials as topic,
【저자키워드】 coronavirus, Vaccines, Ethics, randomized controlled trials as topic, adaptive clinical trials as topic,